157 related articles for article (PubMed ID: 17523007)
21. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
Cai J; Zhang Y; Du W; Nan K
J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
[No Abstract] [Full Text] [Related]
22. Surelease or organic solution of ethylcellulose in preparation of sustained release theophylline micromatrices or matrices using spray drying technique.
Afrasiabi Garekani H; Sedighi S; Sadeghi F
Pharm Dev Technol; 2015 Mar; 20(2):204-10. PubMed ID: 24286215
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
24. A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation.
Parodi B; Russo E; Caviglioli G; Baldassari S; Gaglianone N; Schito AM; Cafaggi S
Drug Dev Ind Pharm; 2013 Dec; 39(12):1911-20. PubMed ID: 22681543
[TBL] [Abstract][Full Text] [Related]
25. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
26. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
Gavini E; Rassu G; Muzzarelli C; Cossu M; Giunchedi P
Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825
[TBL] [Abstract][Full Text] [Related]
27. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
Raval JA; Patel JK; Patel MM
Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
[TBL] [Abstract][Full Text] [Related]
28. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
[TBL] [Abstract][Full Text] [Related]
29. Cellulose acetate/chitosan multimicrospheres preparation and ranitidine hydrochloride release in vitro.
Zhou HY; Chen XG; Liu CS; Meng XH; Liu CG; He J; Yu le J
Drug Deliv; 2006; 13(4):261-7. PubMed ID: 16766467
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of bioadhesive microparticles comprised of low degree of quaternization trimethylated chitosan for nasal administration: effect of concentration and molecular weight.
Karavasili C; Katsamenis OL; Bouropoulos N; Nazar H; Thurner PJ; van der Merwe SM; Fatouros DG
Langmuir; 2014 Oct; 30(41):12337-44. PubMed ID: 25247739
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.
Ochiuz L; Peris JE
Med Chem; 2009 Mar; 5(2):191-6. PubMed ID: 19275718
[TBL] [Abstract][Full Text] [Related]
32. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
Patil SB; Sawant KK
J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
[TBL] [Abstract][Full Text] [Related]
33. Properties of chitosan-microencapsulated orange oil prepared by spray-drying and its stability to detergents.
Li Y; Ai L; Yokoyama W; Shoemaker CF; Wei D; Ma J; Zhong F
J Agric Food Chem; 2013 Apr; 61(13):3311-9. PubMed ID: 23473289
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of gelatin and ethylcellulose microparticles designed as platforms to delivery fluoride.
de Francisco LM; Cerquetani JA; Bruschi ML
Drug Dev Ind Pharm; 2013 Nov; 39(11):1644-50. PubMed ID: 23034061
[TBL] [Abstract][Full Text] [Related]
36. Formulation and characterization of ethylcellulose microparticles containing .L-alanyl- L-glutamine peptide.
Villa Nova M; Gonçalves Mde C; Nogueira AC; Herculano Lda S; Medina AN; Bazotte RB; Bruschi ML
Drug Dev Ind Pharm; 2014 Oct; 40(10):1308-17. PubMed ID: 23862977
[TBL] [Abstract][Full Text] [Related]
37. Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal Administration.
Li W; Ba H; Huang P; Zheng A; Yang X
Drug Res (Stuttg); 2018 Dec; 68(12):673-679. PubMed ID: 29966151
[TBL] [Abstract][Full Text] [Related]
38. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan.
Pardeshi CV; Rajput PV; Belgamwar VS; Tekade AR
J Microencapsul; 2012; 29(2):103-14. PubMed ID: 22047546
[TBL] [Abstract][Full Text] [Related]
39. Controlled drug delivery systems based on thiolated chitosan microspheres.
Elhassan Imam M; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2005 Jul; 31(6):557-65. PubMed ID: 16109629
[TBL] [Abstract][Full Text] [Related]
40. Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres.
Gavini E; Rassu G; Ferraro L; Generosi A; Rau JV; Brunetti A; Giunchedi P; Dalpiaz A
J Pharm Sci; 2011 Apr; 100(4):1488-502. PubMed ID: 24081472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
